Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 01)
Brimonidine Tartrate Solution/ Drops
Product Images NDC 70069-568
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 70069-568). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Bottle-label-5ml (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 02)
This text provides information on the usual dosage for Brimonidine Tartrate Ophthalmic Solution 0.1%, which is one drop three times daily to the affected eye(s). It also mentions storage conditions at 15°-25°C (59°-77°F) and that the bottle is filled to 1/2 capacity. The product details include the NDC number, quantity (5mL Sterile), and manufacturer details. It is intended for prescription use only. The text also mentions a code related to manufacturing and advises keeping the area blank and varnish free for overprinting LOT and EXP details.*
Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 03)
This is a product label for Brimonidine Tartrate Ophthalmic Solution 0.1% manufactured by Somerset Therapeutics. The solution is intended for use in the eyes and contains active ingredients such as Brimonidine tartrate along with various inert components. The recommended dosage is one drop three times daily per affected eye. It should be stored at a temperature between 15°C to 25°C. This solution may help manage certain eye conditions, but use should be under the guidance of a healthcare professional.*
Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 04)
Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 05)
This is a description of Brimonidine Tartrate Ophthalmic Solution 0.1%, manufactured by Somerset Therapeutics, LLC in Somerset, NJ. The product is made in India and is a sterile eye drop solution indicated for ophthalmic use. It contains Brimonidine Tartrate as an active ingredient and includes various inactive ingredients such as boric acid, calcium chloride, and sodium chloride. The usual dosage is one drop three times daily to the affected eye(s). The product should be stored at 15°-25°C (59°-77°F). For more information or customer care, you can contact 1-800-417-9175.*
Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 06)
This text is about an ophthalmic solution containing Brimonidine tartrate 0.1%. It is prescribed for use three times daily in the affected eye(s). The solution is sterile and should be stored at 15°-25°C. The product is manufactured for Somerset Therapeutics, LLC and made in India. It contains a preservative, iPRES 25 - Stabilized Oxychloro Complex (0.005%). The National Drug Code (NDC) is 70069-568-01. Additionally, the packaging contains information about keeping an area blank for printing LOT and EXP details.*
Image (5a808f88 Afeb 4ab3 B005 56b68b27dc7f 07)
This is a product label for Brimonidine Tartrate Ophthalmic Solution 0.1% manufactured for Somerset Therapeutics LLC in Somerset, NJ. The solution is made in India and is used for ophthalmic purposes. It contains brimonidine tartrate as the active ingredient and a variety of inactive ingredients. The usual dosage is one drop three times daily to the affected eye(s). Instructions for storage recommend storing between 15°C-25°C (59°F-77°F). It is available by prescription only and the NDC number is 70069-568-01. For customer care, a number is provided: 1-800-417-9175.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
